June 14, 2024

1425-P: Determinants of Cost-Related Medication Nonadherence in Adults with Diabetes in the United States, 2015 to 2018

Key Points

Key points are not available for this paper at this time.

Abstract

Introduction 95% CI: 0.83 - 1.36). Conclusion: This cross-sectional study reveals that 1 in 10 diabetic individuals report nonadherence due to cost-related issues. Addressing financial barriers and enhancing healthcare accessibility, especially in marginalized communities, can potentially mitigate CRN and improve overall health outcomes. Disclosure C. Wu: None. Y. Weng: None. M. Islam: None.

Bookmark

Cite This Study

Wu et al. (Fri,) studied this question.

synapsesocial.com/papers/68e64c4eb6db6435875dd2ef https://doi.org/https://doi.org/10.2337/db24-1425-p

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Association of Social Determinants of Health with Primary and Cost-Related Medication Nonadherence Among Adult Patients with Diabetes2026
2Cost-related medication nonadherence in adults with COPD in the United States 2013–20202024 · 8 citations
3Factors affecting Cost-Related Medication Non-Adherence among US population with Cardiovascular Risk Factors2024
4The impact of multimorbidity and sociodemographic factors on cost-related medication nonadherence2026
51452-P: Financial Toxicity and Cost-Related Nonadherence (CRN) in Adults with Type 1 Diabetes (T1D)—Prevalence and Associations with Social Determinants of Health2024

Bookmark